Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

Abstract

We discuss the case of a 74-year old male patient with mantle cell lymphoma, who faced severe CMV infection after the fifth cycle of first-line chemo-immunotherapy with a dose-reduced bendamustine and rituximab regimen.

Keywords

• Mantle cell lymphoma
• Bendamustine
• CD4 lymphopenia
• Non Hodgkin-s lymphoma
• Cytomegalovirus